Evidence-based recommendations for comprehensive regulatory guidelines in medical devices: the imperative for global...

The medical device industry has experienced a significant upsurge in the number, diversity, and complexity of devices over the last two decades. As the global demand for medical devices grows, regulatory frameworks across major economies, including the USA, Europe, India, China, and Australia, have evolved to ensure safety, quality, and efficacy. This review critically examines the regulatory guidelines for medical devices across these regions, emphasizing the need for harmonization to streamline approval processes and reduce regulatory barriers. While countries like the USA and Europe have well-established regulatory systems-such as the Food and Drug Authority (FDA) and European Medicines Agency (EMA)-other nations, including India, are rapidly advancing their frameworks, as seen with the introduction of the Indian Medical Device Rules, 2017, and subsequent amendments. Global initiatives, such as the Global Harmonization Task Force (GHTF), Central Drug Standard Control Organisation (CDSCO), EU Medical Device Regulations (MDR), In Vitro Diagnostic Regulation (IVDR), and the International Medical Device Regulators Forum (IMDRF), have made strides in fostering collaboration, yet disparities remain. Harmonized regulations would mitigate challenges related to device registration, manufacturing, and post-market surveillance, expediting access to high-quality, safe medical devices. The review also highlights the growing prevalence of drug-device combination products, their regulatory complexities, and the importance of aligning regulatory practices globally. A harmonized regulatory framework is essential to promote innovation, reduce duplication of work, and ensure the timely availability of medical devices to patients in need. This review explores the evolution of medical devices from ancient practices to modern technologies, emphasizing projected market growth and the need for regulatory harmonization to facilitate innovation and access. It also assesses how emerging technologies are shaping future regulatory frameworks.